Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 99.98% is 246% above its 5-year average of -68.32%, near the high end of its 5-year range (-718.83%–100.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.61% above its 12-month average of 99.37%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
99.98%
GROSS MARGIN AVG TTM
99.37%
GROSS MARGIN AVG 3Y
99.69%
GROSS MARGIN AVG 5Y
-68.32%
GROSS MARGIN AVG 10Y
-365.51%
GROSS MARGIN AVG 15Y
-242.90%
GROSS MARGIN AVG 20Y
-185.14%
CURRENT VS TTM AVG
+0.61%
CURRENT VS 3Y AVG
+0.29%
CURRENT VS 5Y AVG
+246.35%
CURRENT VS 10Y AVG
+127.35%
CURRENT VS 15Y AVG
+141.16%
CURRENT VS 20Y AVG
+154.00%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+141.61%
vs the sector median at left
Arbutus Biopharma Corp
Market Cap
$884.97M
Gross Margin
99.98%
TTM Avg
99.37%
3Y Avg
99.69%
5Y Avg
-68.32%
Market Cap
$887.99M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$878.73M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$869.01M
Gross Margin
35.27%
TTM Avg
46.37%
3Y Avg
58.90%
5Y Avg
58.90%
Market Cap
$864.93M
Gross Margin
44.60%
TTM Avg
46.45%
3Y Avg
50.53%
5Y Avg
59.76%
Market Cap
$859.05M
Gross Margin
91.39%
TTM Avg
91.47%
3Y Avg
93.85%
5Y Avg
95.64%
Market Cap
$919.11M
Gross Margin
65.08%
TTM Avg
65.58%
3Y Avg
65.74%
5Y Avg
65.17%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $884.97M | 99.98% | 99.37% | 99.69% | -68.32% |
| Bioventus Inc. (BVS)vs › | $887.50M | 68.00% | 67.52% | 65.94% | 67.78% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | 0.00% | 0.00% | 0.00% | 0.00% |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $878.73M | 100.00% | 100.00% | 100.00% | 100.00% |
| SL Science Holding Ltd (SLBT)vs › | $869.01M | 35.27% | 46.37% | 58.90% | 58.90% |
| SI-BONE, Inc. (SIBN)vs › | $865.92M | 79.53% | 79.30% | 80.66% | 83.15% |
| QuidelOrtho Corporation (QDEL)vs › | $864.93M | 44.60% | 46.45% | 50.53% | 59.76% |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $859.05M | 91.39% | 91.47% | 93.85% | 95.64% |
| HealthStream, Inc. (HSTM)vs › | $919.11M | 65.08% | 65.58% | 65.74% | 65.17% |
| MoonLake Immunotherapeutics (MLTX)vs › | $920.21M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
100.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2026-03-31 | 99.99% |
| 2025-12-31 | 98.95% |
| 2025-09-30 | 97.92% |
| 2025-06-30 | 100.00% |
| 2025-03-31 | -407.88% |
| 2024-12-31 | -459.72% |
| 2024-09-30 | 100.00% |
| 2024-06-30 | 100.00% |
| 2024-03-31 | 100.00% |
| 2023-12-31 | -718.83% |
| 2023-09-30 | 100.00% |
| 2023-06-30 | 100.00% |
| 2023-03-31 | 100.00% |
| 2022-12-31 | -267.48% |
| 2022-09-30 | 100.00% |
| 2022-06-30 | 100.00% |
| 2022-03-31 | 100.00% |
| 2021-12-31 | -499.25% |
| 2021-09-30 | 100.00% |
| 2021-06-30 | -578.36% |
| 2021-03-31 | -552.25% |
| 2020-12-31 | -587.01% |
| 2020-09-30 | -692.19% |
| 2020-06-30 | -591.22% |
| 2020-03-31 | -598.59% |
| 2019-12-31 | -667.49% |
| 2019-09-30 | -479.26% |
| 2019-06-30 | -1851.00% |
| 2019-03-31 | -2066.72% |
| 2018-12-31 | -559.30% |
| 2018-09-30 | -943.86% |
| 2018-06-30 | -1214.79% |
| 2018-03-31 | -871.38% |
| 2017-12-31 | -603.31% |
| 2017-09-30 | -125.44% |
| 2017-06-30 | -1386.53% |
| 2017-03-31 | -5802.98% |
| 2016-12-31 | 8897.95% |
| 2016-09-30 | -1933.33% |
| 2016-06-30 | -4823.95% |
| 2016-03-31 | -2079.77% |
| 2015-12-31 | -17.48% |
| 2015-09-30 | -302.31% |
| 2015-06-30 | -185.29% |
| 2015-03-31 | -125.48% |
| 2014-12-31 | -173.61% |
| 2014-09-30 | -113.41% |
| 2014-06-30 | -413.42% |
| 2014-03-31 | -85.19% |
| 2013-12-31 | 7.22% |
| 2013-09-30 | -85.85% |
| 2013-06-30 | -72.79% |
| 2013-03-31 | -90.81% |
| 2012-12-31 | -88.67% |
| 2012-09-30 | -1.77% |
| 2012-06-30 | 1.31% |
| 2012-03-31 | -16.06% |
| 2011-12-31 | 0.04% |
| 2011-09-30 | -5.30% |
| 2011-06-30 | -40.62% |
| 2011-03-31 | -29.84% |
| 2010-12-31 | -15602629.30% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | -108.50% |
| 2010-03-31 | -121.27% |
| 2009-12-31 | -18.92% |
| 2009-09-30 | -35.31% |
| 2009-06-30 | -15.97% |
| 2009-03-31 | -25.62% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | -2.66% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 100.00% |
